Results 261 to 270 of about 15,351,209 (418)

Cancer nanomedicine: progress, challenges and opportunities

Nature Reviews. Cancer, 2016
Jinjun Shi, P. Kantoff, R. Wooster, O. Farokhzad   +3 more
semanticscholar   +1 more source

Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression

Molecular Oncology, EarlyView.
Immune status significantly influences cancer progression. This study used plasma proteomics to analyze benign 67NR and malignant 4T1 breast tumor models at early and late tumor stages. Immune‐related proteins–osteopontin (Spp1), lactotransferrin (Ltf), calreticulin (Calr) and peroxiredoxin 2 (Prdx2)–were associated with systemic myeloid‐derived ...
Yeon Ji Park, Jae Won Oh, Hyewon Chung, Jung Won Kwon, Yi Rang Na, Kwang Pyo Kim, Seung Hyeok Seok   +6 more
wiley   +1 more source

Walking Speed and Risk of Cancer in Two Prospective Cohort Studies. [PDF]

J Cachexia Sarcopenia Muscle
Mak JKL, Tan KCB, Jylhävä J, Hägg S, Cheung CL.   +4 more
europepmc   +1 more source

The Persistence of Allergic Eczematous Sensitivity and the Cross-Sensitivity Pattern to Paraphenylenediamine**From The Department of Dermatology and Syphilology of the New York University Post Graduate Medical School (Dr. Marion B. Sulzberger, chairman) and The Skin and Cancer Unit of the New York University Hospital.

, 1958
Alexander A. Fisher, Alfred Pelzig, Norman B. Kanof   +2 more
openalex   +1 more source

The Pathology and Results of Treatment of Cancer of the Anal Region [PDF]

, 1959
B C Morson
openalex   +1 more source

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

International Journal of Cancer, 2010
J. Ferlay, Hai-rim Shin, F. Bray, D. Forman, C. Mathers, D. Parkin   +5 more
semanticscholar   +1 more source

Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance

Molecular Oncology, EarlyView.
Cellular heterogeneity is a major cause of drug resistance in cancer. Segeren et al. used single‐cell transcriptomics to investigate gene expression events that correlate with sensitivity to the DNA‐damaging drugs gemcitabine and prexasertib. They show that dampened expression of transcription factor FOXM1 and its target genes protected cells against ...
Hendrika A. Segeren, Kathryn A. Wierenga, Frank M. Riemers, Elsbeth A. van Liere, Bart Westendorp   +4 more
wiley   +1 more source

Using Integrative Therapies to Improve Patient-Reported Outcomes in Breast Cancer Survivors: A Living Evidence-Based Clinical Practice Guideline. [PDF]

J Evid Based Med
Lu T, Lai H, Lin H, Ma F, Hou L, Tang L, Zhu Y, Mao H, Zhang AL, Lee MS, Ozaki A, Schveitzer MC, Zhao H, Zhong L, Jia B, Fan L, Huang J, Han B, Zhao W, Ge L, Liu J, Huang L.   +21 more
europepmc   +1 more source

Researches on the pathology and diagnosis of cancers of the lung and mediastinum [PDF]

William Stokes
openalex   +1 more source

The Influence of Heredity on Disease, with Special Reference to Tuberculosis, Cancer and Diseases of the Nervous System [PDF]

, 1909
William S. Church
openalex   +1 more source